Yahoo Finance One Aura Biosciences Insider Raised Stake By 232% In Previous Year
Insiders were net buyers of Aura Biosciences, Inc.'s (NASDAQ:AURA ) stock during the past year. That is, insiders bought more stock than they sold.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Aura Biosciences
Aura Biosciences Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider purchase was by Independent Chairman of the Board David Johnson for US$1.4m worth of shares, at about US$7.30 per share. So it's clear an insider wanted to buy, at around the current price, which is US$7.49. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the Aura Biosciences insider decided to buy shares at close to current prices. David Johnson was the only individual insider to buy shares in the last twelve months.
David Johnson purchased 219.67k shares over the year. The average price per share was US$7.30. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Aura Biosciences insiders own about US$5.4m worth of shares (which is 1.5% of the company). We do generally prefer see higher levels of insider ownership.
What Might The Insider Transactions At Aura Biosciences Tell Us?
There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. The transactions are fine but it'd be more encouraging if Aura Biosciences insiders bought more shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Aura Biosciences. For instance, we've identified 4 warning signs for Aura Biosciences (2 don't sit too well with us) you should be aware of.
But note: Aura Biosciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
